Karlsson, Filip http://orcid.org/0000-0002-0860-1500
Kallas, Tomasz
Thiagarajan, Divya
Karlsson, Max http://orcid.org/0000-0002-7000-4416
Schweitzer, Maud
Navarro, Jose Fernandez http://orcid.org/0000-0002-4035-5258
Leijonancker, Louise
Geny, Sylvain
Pettersson, Erik
Rhomberg-Kauert, Jan http://orcid.org/0009-0001-5214-9697
Larsson, Ludvig
van Ooijen, Hanna
Petkov, Stefan
González-Granillo, Marcela
Bunz, Jessica
Dahlberg, Johan
Simonetti, Michele http://orcid.org/0000-0003-3322-1697
Sathe, Prajakta
Brodin, Petter http://orcid.org/0000-0002-8103-0046
Barrio, Alvaro Martinez
Fredriksson, Simon http://orcid.org/0009-0007-0673-3503
Funding for this research was provided by:
The presented work was funded by the Wellcome Leap ΔTissue Program and Stiftelsen för Strategisk Forskning, SSF.
Brodin is supported by a Proof-of-Concept grant from Knut & Alice Wallenberg Foundation
Article History
Received: 7 July 2023
Accepted: 2 April 2024
First Online: 8 May 2024
Competing interests
: All authors are employees or advisors to Pixelgen Technologies, which commercializes products based on Molecular Pixelation. They are also shareholders or stock option holders of the company.
: All PBMC samples were purchased from a Karolinska Hospital blood bank drawn from healthy volunteers with informed consent, and sample identity and other medical information were withheld.